Abstract: A display apparatus includes: a plurality of pixel circuits at a display area, the display area having a non-quadrangular shape; a first signal line extending on the display area in a first direction, and electrically connected to a first pixel circuit from among the plurality of pixel circuits; a first voltage line extending on the display area in the first direction; a first load compensation capacitor adjacent to an end portion of the first signal line and an end portion of the first voltage line; a test circuit outside the display area; an output line electrically connected to the test circuit; and a connection portion configured to electrically connect the output line, the first signal line, and an electrode of the first load compensation capacitor to each other.

Abstract: A display device includes a circular display area and a non-display area surrounding the circular display area. The display device may further include a load matcher disposed adjacent to an edge of the circular display area in the circular display area, a pixel disposed in the circular display area, spaced apart from the non-display area by the load matcher, and connected to the load matcher, and a repair pixel disposed adjacent to the edge of the circular display area in the non-display area, and connected to the pixel.

Abstract: The present disclosure relates to a microcarrier for cell culture comprising: polystyrene-based particles containing at least one or more of hydrocarbon oil having 12 or more carbon atoms, or pores derived therefrom, a method for producing the same, and a cell culture composition using the same.

Abstract: The present application relates to microcarrier particles for cell culture, a method for preparing the particles, and a cell culture medium composition including the particles. According to the present application, a microcarrier having a high degree of uniformity in shape or form, having porosity, and advantageous for cell attachment and isolation of cultured cells is provided.

Abstract: The present disclosure relates to a method of preparing polymeric microparticles that can realize excellent mechanical strength and stability as well as high crosslinking efficiency and production yield, polymeric microparticles, medical compositions, cosmetic compositions, medical articles and cosmetic articles comprising the same.

Abstract: The present disclosure relates to a microcarrier that has excellent adhesion to cells and also is easily isolated from cells after culturing, a method for producing the same, and a cell culture method using the same.

Abstract: The present disclosure provides a method for preparing a microcapsule and a microcapsule prepared thereby capable of selective release of oils and preventing volatilization of oils while maintaining long-term performance by improving storage stability of the oil contained in the capsule.

Abstract: The present disclosure relates to a method for preparing a biodegradable and eco-friendly organic-inorganic hybrid microcapsule having few toxic substances with high versatility and economical efficiency by using a pickering emulsion method with a specific outer wall reinforcing material, a reactive material, and inorganic nanoparticles, and allowing polymerization of the outer wall reinforcing material and the reactive material to proceed at the interface. Specifically, the organic-inorganic hybrid microcapsule can stably support an active ingredient and then effectively express its activity by pressure, and exhibit a characteristic of gradually releasing the active ingredient at room temperature.

Abstract: The present invention relates to a pharmaceutical combined composition for preventing or treating cancer comprising a compound of formula 1 or a pharmaceutically acceptable salt thereof and topoisomerase inhibitor as active ingredients. The pharmaceutical combined composition of the present invention specifically inhibits cell proliferation and induces apoptosis as to various cancers such as colorectal cancer and ovarian cancer that a vascular disrupting agent cannot treat due to a complex inhibition mechanism of neoplasm of the compound of formula 1 and the pharmaceutically acceptable salt thereof and topoisomerase inhibitor, and thereby it can be usefully used for preventing and treating cancer.

Abstract: The present invention relates to a pharmaceutical combined composition for preventing or treating cancer comprising a compound of formula 1 or a pharmaceutically acceptable salt thereof and topoisomerase inhibitor as active ingredients. The pharmaceutical combined composition of the present invention specifically inhibits cell proliferation and induces apoptosis as to various cancers such as colorectal cancer and ovarian cancer that a vascular disrupting agent cannot treat due to a complex inhibition mechanism of neoplasm of the compound of formula 1 and the pharmaceutically acceptable salt thereof and topoisomerase inhibitor, and thereby it can be usefully used for preventing and treating cancer.